From Medscape Neurology

Medscape Coverage from the

International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders (AD/PD) 2017

March 29 - April 02, 2017; Vienna, Austria

March 29 - April 02, 2017 Vienna, Austria

Conference News

AD/PD Brain Iron May Distinguish Parkinson's From Other Tremors
Medscape Medical News, April 10, 2017
AD/PD Ventricular Enlargement Plus Idiopathic NPH Symptoms May Up Risk for Dementia
Medscape Medical News, April 6, 2017
AD/PD Near-Vision Loss Linked to Increased Dementia
Medscape Medical News, April 4, 2017

AD/PD Volunteering, Living Alone Linked to Better Cognition in Women
Medscape Medical News, March 31, 2017
AD/PD Higher Education Neuroprotective Only During Early Aging
Medscape Medical News, March 31, 2017
AD/PD Metformin Linked to Dementia, Parkinson's in Patients With T2DM
Medscape Medical News, March 30, 2017

Popular News from AD/PD 2015

Finally, a Big Win for a Monoclonal in Alzheimer's Monoclonal antibodies may yet be an answer for treating Alzheimer's disease, results of an early but very encouraging study have shown. Aducanumab lowered amyloid burden and slowed cognitive decline.
Medscape Medical News, Mar 23, 2015
Green Tea Linked to Lower Risk for Cognitive Decline Frequent consumption of green tea is associated with a dose-dependent lower risk for cognitive decline among Japanese elderly. Black tea and coffee had no effect.
Medscape Medical News, Mar 25, 2015
New Drug Greatly Reduces Amyloid in CSF, Plasma A once-daily, oral secretase inhibitor greatly reduces levels of amyloid in plasma and CSF with a prolonged effect, a study shows. The compound works regardless of APOE epsilon 4 carrier status.
Medscape Medical News, Mar 24, 2015 8:28:52 AM

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resource